KKR related stories
All articles and analysis
KKR agrees to $3.55bn satellite buyoutIn the year’s biggest US private equity deal, KKR has agreed to buy PanAmSat from its majority stakeholder, DirectTV Group.
- KKR leads $250m pharma round
Jazz Pharmaceuticals snags one of the largest second round financings on record for a speciality pharma company without any commercialized drugs.
- Former Primedia head teams with Spectrum
Charles McCurdy, the co-founder and former president of the targeted media giant, and Spectrum Equity Investors have announced a joint initiative of up to $200m to invest in niche media businesses.
- Tom Hicks to leave Hicks Muse next year
The co-founder of one of the industry’s most established and storied buyout firms has told investors he will step down a year from now to focus on his new ‘day job’ as sports team owner and family office head. Lyndon Lea steps up.
- KKR in $1.5bn mattress buyout
In the third private equity mattress deal in as many months, the New York buyout firm has agreed to acquire Sealy, the world’s largest maker of bedding products, from a group of private equity firms.
- Former Tomkins chief to join Lupus Capital
Ex Tomkins CEO Greg Hutchings is to become executive chairman of investment company Lupus Capital and invest more than £2.1m in the business.
- KKR’s Richardson joins Hicks Muse
Neil Richardson, a former partner and senior member of KKR’s London office, has moved to rival Hicks, Muse, Tate & Furst to join the firm’s European team.
- Sponsors bet on chemicals
100 European chemicals companies are now under private equity ownership, but realisations are a challenge, according to a new report.
- Autogrill could be Italy’s next mega-deal
The fast-growing Italian private equity market could be delivered another boost if private equity firms follow through on their reported interest in restaurant group Autogrill.
- VCs eye E2.5bn German chemicals unit
Germany’s MG Technologies has set the first week of December as the deadline for first-round bids for its Dinamit Nobel chemicals unit, which has attracted considerable private equity interest.